Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.
Torre-Amione G, Anker SD, Bourge RC, Colucci WS, Greenberg BH, Hildebrandt P, Keren A, Motro M, Moyé LA, Otterstad JE, Pratt CM, Ponikowski P, Rouleau JL, Sestier F, Winkelmann BR, Young JB; Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy Investigators. Torre-Amione G, et al. Among authors: moye la. Lancet. 2008 Jan 19;371(9608):228-36. doi: 10.1016/S0140-6736(08)60134-8. Lancet. 2008. PMID: 18207018 Clinical Trial.
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design.
Torre-Amione G, Bourge RC, Colucci WS, Greenberg B, Pratt C, Rouleau JL, Sestier F, Moyé LA, Geddes JA, Nemet AJ, Young JB; ACCLAIM Investigators. Torre-Amione G, et al. Among authors: moye la. Can J Cardiol. 2007 Apr;23(5):369-76. doi: 10.1016/s0828-282x(07)70770-5. Can J Cardiol. 2007. PMID: 17440642 Free PMC article.
Design of a randomized, placebo-controlled multicenter trial on the long-term effects of intermittent transdermal nitroglycerin on left ventricular remodeling after acute myocardial infarction. Transdermal Nitroglycerin Investigators Group.
Pratt CM, Mahmarian JJ, Morales-Ballejo H, Casareto R, Moyé LA. Pratt CM, et al. Among authors: moye la. Am J Cardiol. 1998 Mar 15;81(6):719-24. doi: 10.1016/s0002-9149(97)01003-5. Am J Cardiol. 1998. PMID: 9527081 Clinical Trial.
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
Shah AM, Pfeffer MA, Hartley LH, Moyé LA, Gersh BJ, Rutherford JD, Lamas GA, Rouleau JL, Braunwald E, Solomon SD. Shah AM, et al. Among authors: moye la. Am J Cardiol. 2010 Oct 1;106(7):911-6. doi: 10.1016/j.amjcard.2010.05.021. Epub 2010 Aug 11. Am J Cardiol. 2010. PMID: 20854949 Clinical Trial.
Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial.
Mahmarian JJ, Moyé LA, Chinoy DA, Sequeira RF, Habib GB, Henry WJ, Jain A, Chaitman BR, Weng CS, Morales-Ballejo H, Pratt CM. Mahmarian JJ, et al. Among authors: moye la. Circulation. 1998 May 26;97(20):2017-24. doi: 10.1161/01.cir.97.20.2017. Circulation. 1998. PMID: 9610531 Clinical Trial.
162 results